⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Shamla Pharmaceutical Industries and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Shamla Pharmaceutical Industries
↗Makkah Province, Saudi Arabia
Shamla Pharmaceutical Industries is a Saudi Arabia-based pharmaceutical manufacturing company. It was established as a strategic partnership between Zimmo Trading Est (Saudi Arabia), Global Napi Pharmaceuticals (Egypt), and Unipharma Pharmaceutical Industries (Syria) to localize pharmaceutical manufacturing in the Kingdom of Saudi Arabia, specifically within the King Abdullah Economic City (KAEC) Industrial Valley.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:-
Industry:Pharmaceuticals
Sub-Industry:Pharmaceutical Manufacturing
SIZE & FINANCIALS
Employees:51-200
Founded:2011
Ownership:private
Status:operating
FUNDING
Investors:Zimmo Trading Est, Global Napi Pharmaceuticals, Unipharma Pharmaceutical Industries
PIPELINE
Stage:Commercial
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Zimmo Trading Est, Global Napi Pharmaceuticals, Unipharma Pharmaceutical Industries, Emaar (KAEC)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Hossam Mitwally - Shareholder Representative
LINKS
Website:shamlapharma.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Shamla Pharmaceutical Industries. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.